Characterization of the Emerging B.1.621 Variant of Interest of SARS-CoV-2

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genetic diversity has the potential to impact the virus transmissibility and the escape from natural infection- or vaccine-elicited neutralizing antibodies. Here, representative samples from circulating SARS-CoV-2 in Colombia between January and April 2021, were processed for genome sequencing and lineage determination following the nanopore amplicon ARTIC network protocol and PANGOLIN pipeline. This strategy allowed us to identify the emergence of the B.1.621 lineage, considered a variant of interest (VOI) with the accumulation of several substitutions affecting the Spike protein, including the amino acid changes I95I, Y144T, Y145S and the insertion 146 N in the N-terminal domain, R346K, E484K and N501Y in the Receptor binding Domain (RBD) and P681H in the S1/S2 cleavage site of the Spike protein. The rapid increase in frequency and fixation in a relatively short time in Magdalena, Atlantico, Bolivar, Bogotá D.C, and Santander that were near the theoretical herd immunity suggests an epidemiologic impact. Further studies will be required to assess the biological and epidemiologic roles of the substitution pattern found in the B.1.621 lineage.

Citing Articles

Learning the fitness dynamics of pathogens from phylogenies.

Lefrancq N, Duret L, Bouchez V, Brisse S, Parkhill J, Salje H Nature. 2025; 637(8046):683-690.

PMID: 39743587 PMC: 11735385. DOI: 10.1038/s41586-024-08309-9.

Systematic surveillance of SARS-CoV-2 reveals dynamics of variant mutagenesis and transmission in a large urban population.

Aynaud M, Caldwell L, Al-Zahrani K, Barutcu S, Chan K, Obersterescu A Nat Commun. 2024; 15(1):10795.

PMID: 39738001 PMC: 11685962. DOI: 10.1038/s41467-024-55031-1.

Routes of importation and spatial dynamics of SARS-CoV-2 variants during localized interventions in Chile.

Gutierrez B, Tsui J, Pullano G, Mazzoli M, Gangavarapu K, Inward R PNAS Nexus. 2024; 3(11):pgae483.

PMID: 39525554 PMC: 11547135. DOI: 10.1093/pnasnexus/pgae483.

Genetic diversity and genomic epidemiology of SARS-CoV-2 during the first 3 years of the pandemic in Morocco: comprehensive sequence analysis, including the unique lineage B.1.528 in Morocco.

Djorwe S, Malki A, Nzoyikorera N, Nyandwi J, Zebsoubo S, Bellamine K Access Microbiol. 2024; 6(10).

PMID: 39376591 PMC: 11457919. DOI: 10.1099/acmi.0.000853.v4.

Some mechanistic underpinnings of molecular adaptations of SARS-COV-2 spike protein by integrating candidate adaptive polymorphisms with protein dynamics.

Ose N, Campitelli P, Modi T, Kazan I, Kumar S, Ozkan S Elife. 2024; 12.

PMID: 38713502 PMC: 11076047. DOI: 10.7554/eLife.92063.

References

Laiton-Donato K, Villabona-Arenas C, Usme-Ciro J, Franco-Munoz C, Alvarez-Diaz D, Villabona-Arenas L . Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2, Colombia. Emerg Infect Dis. 2020; 26(12):2854-2862. PMC: 7706936. DOI: 10.3201/eid2612.202969. View

Greaney A, Loes A, Crawford K, Starr T, Malone K, Chu H . Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host Microbe. 2021; 29(3):463-476.e6. PMC: 7869748. DOI: 10.1016/j.chom.2021.02.003. View

Abdool Karim S, de Oliveira T . New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications. N Engl J Med. 2021; 384(19):1866-1868. PMC: 8008749. DOI: 10.1056/NEJMc2100362. View

Jeyanathan M, Afkhami S, Smaill F, Miller M, Lichty B, Xing Z . Immunological considerations for COVID-19 vaccine strategies. Nat Rev Immunol. 2020; 20(10):615-632. PMC: 7472682. DOI: 10.1038/s41577-020-00434-6. View

Wang Z, Schmidt F, Weisblum Y, Muecksch F, Barnes C, Finkin S . mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021; 592(7855):616-622. PMC: 8503938. DOI: 10.1038/s41586-021-03324-6. View

Wibmer C, Ayres F, Hermanus T, Madzivhandila M, Kgagudi P, Oosthuysen B . SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. Nat Med. 2021; 27(4):622-625. DOI: 10.1038/s41591-021-01285-x. View

Bal A, Destras G, Gaymard A, Stefic K, Marlet J, Eymieux S . Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020. Euro Surveill. 2021; 26(3). PMC: 7848679. DOI: 10.2807/1560-7917.ES.2021.26.3.2100008. View

Laiton-Donato K, Usme-Ciro J, Franco-Munoz C, Alvarez-Diaz D, Ruiz-Moreno H, Reales-Gonzalez J . Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K. Front Med (Lausanne). 2021; 8:697605. PMC: 8273171. DOI: 10.3389/fmed.2021.697605. View

Xie X, Liu Y, Liu J, Zhang X, Zou J, Fontes-Garfias C . Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera. Nat Med. 2021; 27(4):620-621. DOI: 10.1038/s41591-021-01270-4. View

10.

Liu Z, VanBlargan L, Bloyet L, Rothlauf P, Chen R, Stumpf S . Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization. Cell Host Microbe. 2021; 29(3):477-488.e4. PMC: 7839837. DOI: 10.1016/j.chom.2021.01.014. View

11.

Davies N, Abbott S, Barnard R, Jarvis C, Kucharski A, Munday J . Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021; 372(6538). PMC: 8128288. DOI: 10.1126/science.abg3055. View

12.

Garcia-Beltran W, Lam E, St Denis K, Nitido A, Garcia Z, Hauser B . Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell. 2021; 184(9):2523. PMC: 8082941. DOI: 10.1016/j.cell.2021.04.006. View

13.

Rees-Spear C, Muir L, Griffith S, Heaney J, Aldon Y, Snitselaar J . The effect of spike mutations on SARS-CoV-2 neutralization. Cell Rep. 2021; 34(12):108890. PMC: 7936541. DOI: 10.1016/j.celrep.2021.108890. View